|
Chow, H-H. Sherry |
University Of Arizona |
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet) |
3UG1CA242596-02S1 |
Lung and Upper Aerodigestive Cancer, Cancer Prevention Clinical Trials Network |
PA-18-906 |
|
CHOW, ERIC JESSEN |
FRED HUTCHINSON CANCER RESEARCH CENTER |
Improving treatment of cardiovascular risk factors in childhood cancer survivors |
5R01CA204378-02 |
Supportive Care and Symptom Management, Cardiotoxicity |
PA-13-302 |
|
CHOW, ERIC JESSEN |
FRED HUTCHINSON CANCER RESEARCH CENTER |
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy |
1R01CA211996-01 |
Supportive Care and Symptom Management, Cardiotoxicity |
PA-13-302 |
|
Chung, Fung-Lung |
Georgetown University |
gamma-OHPdG as a prognostic biomarker of HCC recurrence and its prevention |
5U01CA220477-03 |
Cancer Biomarkers |
PAR-15-307 |
|
Chung, Ki Young |
Prisma Health-Upstate |
NCORP of the Carolinas (Greenville Health System NCORP) |
5UG1CA189972-07 |
Community Oncology and Prevention Trials, NCI Community Oncology Research Program, NCORP Community Sites |
RFA-CA-18-016 |
|
Clapper, Margie L. |
Research Inst Of Fox Chase Can Ctr |
Targeted Chemoprevention of Flat and Polypoid Colitis-associated Dysplasias |
5R01CA183301-05 |
Chemopreventive Agent Development |
PA-13-302 |
|
Clinton, Steven K |
Ohio State University |
Modulation of antitumor immunity by dietary soy and its isoflavone constituents |
5R01CA169363-06 |
Nutritional Science |
PA-11-260 |
|
Clinton, Steven K |
Ohio State University |
Translating Novel Antitumor Targets of Vitamin E into New Chemopreventive Agents |
5R01CA172576-05 |
Chemopreventive Agent Development |
PA-11-260 |
|
Cohen, Lorenzo |
University Of Tx Md Anderson Can Ctr |
Community-Based, Phase III Trial of acupuncture to treat chronic Xerostomia |
4R01CA160880-05 |
Community Oncology and Prevention Trials, Supportive Care and Symptom Management, Nutrition, Oral Complications |
PA-10-067 |
|
Cole, Peter D |
Rbhs -Cancer Institute Of New Jersey |
Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL |
5R01CA220568-03 |
Community Oncology and Prevention Trials, Supportive Care and Symptom Management, Cognitive Dysfunction, Pediatrics/Adolescents/Young Adult |
PAR-16-218 |
|
Conklin, Heather M |
St. Jude Children'S Research Hospital |
Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Low Grade Glioma |
5R21CA218625-02 |
Community Oncology and Prevention Trials, Supportive Care and Symptom Management, Cognitive Dysfunction |
PAR-16-176 |
|
Conley, Yvette P |
University Of Pittsburgh At Pittsburgh |
Epigenomics of Neurocognitive Function in Breast Cancer |
5R01CA221882-03 |
Community Oncology and Prevention Trials, Supportive Care and Symptom Management, Cognitive Dysfunction |
PA-16-160 |
|
Cooperberg, Matthew R |
University Of California, San Francisco |
Improving Prostate Cancer Outcome Prediction Through Noninvasive exRNA Assessment |
5R01CA198145-05 |
Cancer Biomarkers |
PA-13-302 |
|
Cope, Timothy C |
Georgia Institute Of Technology |
Novel Path to Chronic Sensorimotor Dysfunction and Treatment for Chemotherapy |
5R01CA221363-03 |
Community Oncology and Prevention Trials, Supportive Care and Symptom Management, Physical Functioning |
PA-16-160 |
|
Crandall, Jill P |
Albert Einstein College Of Medicine |
20/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project |
5U01DK048349-29 |
Breast and Gynecologic Cancer, DPPOS Study |
RFA-DK-15-503 |
